These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 21652023)
1. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Leder HA; Jabs DA; Galor A; Dunn JP; Thorne JE Am J Ophthalmol; 2011 Sep; 152(3):441-448.e2. PubMed ID: 21652023 [TBL] [Abstract][Full Text] [Related]
2. Outcome of intravitreal triamcinolone in uveitis. Kok H; Lau C; Maycock N; McCluskey P; Lightman S Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868 [TBL] [Abstract][Full Text] [Related]
3. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children. Sallam A; Comer RM; Chang JH; Grigg JR; Andrews R; McCluskey PJ; Lightman S Arch Ophthalmol; 2008 Feb; 126(2):200-5. PubMed ID: 18268210 [TBL] [Abstract][Full Text] [Related]
4. Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis. Salek SS; Leder HA; Butler NJ; Gan TJ; Dunn JP; Thorne JE Ocul Immunol Inflamm; 2013 Aug; 21(4):257-63. PubMed ID: 23617776 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis. Maca SM; Abela-Formanek C; Kiss CG; Sacu SG; Benesch T; Barisani-Asenbauer T Clin Exp Ophthalmol; 2009 May; 37(4):389-96. PubMed ID: 19594566 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema. Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Smith JR; Thorne JE; Flaxel CJ; Jain N; Kim SJ; Maguire MG; Patel S; Weng CY; Yeh S; Kim LA Ophthalmology; 2024 Sep; 131(9):1107-1120. PubMed ID: 38647511 [TBL] [Abstract][Full Text] [Related]
11. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation. Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038 [TBL] [Abstract][Full Text] [Related]
13. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA. Khurana RN; Porco TC Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813 [TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases]. Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis. Steeples LR; Anand N; Moraji J; Jones NP Ocul Immunol Inflamm; 2018; 26(7):997-1004. PubMed ID: 28318344 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis. Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727 [TBL] [Abstract][Full Text] [Related]
18. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide. Lin JM; Chiu YT; Hung PT; Tsai YY Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease. Atmaca LS; Yalçindağ FN; Ozdemir O Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis. McKay KM; Borkar DS; Sevgi DD; Susarla G; Papaliodis GN; Sobrin L Ocul Immunol Inflamm; 2021 Jul; 29(5):857-864. PubMed ID: 31902274 [No Abstract] [Full Text] [Related] [Next] [New Search]